Mutuagung Lestari Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Mutuagung Lestari Tbk. trades at Rp110 (market cap 386.65B, 2.71M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Mutuagung Lestari Tbk. is far larger — about 2.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Mutuagung Lestari Tbk. is more actively traded (2.71M versus 96.7K). Which is the better fit depends on your goals.
| MUTU | OBAT | |
|---|---|---|
Market Cap | 386.65B | 167.37B |
Volume | 2.71M | 96.7K |
Lot | 27.15K | 967 |
Turnover | 300.47M | 23.82M |
Average Price | 110.67 | 246.34 |
Value | 300.47M | 23.82M |
Indicative Equilibrium Price | 110 | 248 |
Indicative Equilibrium Volume | 205 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Mutuagung Lestari Tbk (the Company) was established in the Republic of Indonesia based on Deed No. 6 dated March 2, 1990 of Jacinta Susanti, S.H., Notary in Jakarta. The Company started its commercial operations in 1990.
Read more on MUTU →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →